The pathobiologic implications for treatment: Old and new strategies in the treatment of chronic asthma

Clinics in Chest Medicine

Volumn 21, Issue 2, 2000, Pages 381-395

  Horiuchi, Todd ^b   Castro, Mario ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE; METHYLXANTHINE; NEDOCROMIL; THEOPHYLLINE; ZAFIRLUKAST; ZILEUTON;

ASTHMA; DRUG EFFECT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0033932811     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70273-2     Document Type: Article

References (196)

1. R. Aalbers M. Smith W. Timens Immunohistology in bronchial asthma Respiratory Medicine 87 suppl B 1993 13 21
2. T. Adachi S. Motojima A. Hirata Eosinophil viability-enhancing activity in sputum from patients with bronchial asthma Am J Respir Crit Care Med 151 1995 618 623
3. E. Alton D. Kingsleigh-Smith F. Munkonge Asthma prophylaxis agents alter the function of an airway epithelial chloride channel Am J Respir Cell Mol Biol 14 1996 380 387
4. A. Antczak D. Nowak P. Bialasiewicz Hydrogen peroxide in expired air condensate correlates positively with early steps of peripheral neutrophil activation in asthmatic patients Arch Immunol Ther Exp (Warsz) 47 1999 119 126
5. A. Antczak D. Nowak B. Shariati Increase hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients Eur Respir J 10 1997 1235 1241
6. P. Barnes Effect of corticosteroids on airway hyperresponsiveness Am Rev Respir Dis 141 1990 S70 S76
7. P. Barnes Effect of nedocromil sodium on microvascular leakage J Allergy Clin Immunol 92 1993 197 199
8. P. Barnes Inhaled glucocorticoids for asthma N Engl J Med 332 1995 868 875
9. P. Barnes Mechanisms of action of glucocorticoids in asthma Am J Respir Crit Care Med 154 1996 S21 S27
10. P. Barnes Modulation of neurotransmission in airways Physiol Rev 72 1992 699 729
11. P. Barnes Nitric oxide and airway disease (review) Annals of Medicine 27 1995 389 393
12. P. Barnes R. Pauwels Theophylline in the management of asthma: Time for reappraisal? Eur Respir J 7 1994 579 591
13. E. Bel M. Timmers J. Hermans The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects Am Rev Respir Dis 141 1990 21 28
14. 2-agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease Thorax 46 1991 9 14
15. L. Borish J. Williams S. Johnson Anti-inflammatory effects of nedocromil sodium: Inhibition of alveolar macrophage function Clin Exp Allergy 22 1992 984 990
16. Boulet L.-P. K. Chapman J. Cote Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response Am J Respir Crit Care Med 155 1997 1835 1840
17. D. Boulton J. Fawcett Enantioselective disposition of salbutamol in man following oral and intravenous administration Br J Clin Pharmacol 41 1996 35 40
18. B.L. Bradley M. Azzawi M. Jacobson Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness J Allergy Clin Immunol 88 1991 661 674
19. J. Brown W. Greville K. Finucane Asthma and irreversible airflow obstruction Thorax 39 1984 131 136
20. O. Bruserud The effect of theophylline on T-lymphocyte activation in vitro Clin Immunol Immunopathol 32 1984 111 118
21. C. Burke C. Power A. Norris Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma Eur Respir J 5 1992 73 79
22. P. Butchers C. Vardey M. Johnson Salmeterol: A potent and long-acting inhibitor of inflammatory mediator release from human lung Br J Pharmacol 104 1991 672 676
23. W. Calhoun B. Lavins M. Minkwitz Effect of zafirlukast (Accolate) on cellular mediators of inflammation: Bronchoalveolar lavage fluid findings after segmental antigen challenge Am J Respir Crit Care Med 157 1998 1381 1389
24. 2-agonists: Formoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics Respir Med 93 1999 236 244
25. M. Castro M. Holtzman C. Langbecker Inflammatory changes in asthma following inhaled corticosteroid withdrawal Am J Respir Crit Care Med 155 1997 A287
26. M. Castro J. Marvel D. Hamilos Inflammatory cell influx in asthma precedes changes in pulmonary function following inhaled corticosteroid (ICS) withdrawal Asthma '99 Theory to Treatment 56 1999
27. K. Chapman S. Kesten J. Szalai Regular vs. as-needed inhaled salbutamol in asthma control Lancet 343 1994 1379 1382
28. Chen X.-S. J. Sheller E. Johnson Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene Nature 372 1994 179 182
29. A. Chetta A. Foresi Del Donno M. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma Am J Respir Crit Care Med 153 1996 910 917
30. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma N Engl J Med 327 1992 1198 1203
31. D. Cockcroft K. Murdock Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine J Allergy Clin Immunol 79 1987
32. D. Cockcroft V. Swystun R. Bhagat Interaction of inhaled β2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine Am J Respir Crit Care Med 152 1995 1485 1489
33. D. Cockroft C. McParland S. Britto Regular inhaled salbutamol and airway responsiveness to allergen Lancet 342 1993 833 837
34. S. Coles K. Neill L. Reid Effects of leukotrienes C4 and D4 on glycoprotein and lysozyme secretion by human bronchial mucosa Prostaglandins 25 1983 155 170
35. J. Condemi S. Goldstein C. Kalberg The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma Ann Allergy Asthma Immunol 82 1999 383 389
36. N. Crimi F. Palermo R. Oliveri Comparative study of the effects of nedocromil sodium (4 mg) and sodium cromoglycate (10 mg) on adenosine-induced bronchoconstriction in asthmatic subjects Clin Allergy 18 1988 367 374
37. E. Crimi A. Spanevello M. Neri Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma Am J Respir Crit Care Med 157 1998 4 9
38. G.E. D-Alonzo R.A. Nathan S. Henochowicz Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma JAMA 271 1994 1412 1416
39. B. Dahlen M. Kumlin D. Margolskee The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics Eur Respir J 6 1993 1018 1026
40. S. Dahlen P. Hedqvist S. Hammarstrom Leukotrienes are potent constrictors of human bronchi Nature 288 1980 484 486
41. de Benedictis F. G. Tuteri P. Pazzelli Cromolyn versus nedocromil: Duration of action in exercise-induced asthma in children J Allergy Clin Immunol 96 1995 510 514
42. J.W. DeJong J.P. Teengs D.S. Postma Nedocromil sodium versus albuterol in the management of allergic asthma Am J Respir Crit Care Med 149 1994 91 97
43. Z. Diamant J. Hiltermann van Rensen E. The effect of inhaled leukotriene-D4 and methacholine on sputum cell differentials in asthma Am J Respir Crit Care Med 155 1997 1247 1253
44. Z. Diamant M. Timmers van der Veen H. The effect of MK-0591, a novel 5-lipoxygenase–activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo J Allergy Clin Immunol 95 1995 42 51
45. J. Didonato F. Saatcioglu M. Karin Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids Am J Respir Crit Care Med 154 1996 S11 S15
46. R. Djukanovic W.R. Roche J.W. Wilson Mucosal inflammation in asthma Am Rev Respir Dis 142 1990 434 457
47. R. Djukanovic J.W. Wilson K.M. Britten Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma Am Rev Respir Dis 145 1992 669 674
48. Dompeling E. vanSchayck C. van Grunsven P. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: A 4-year prospective study Ann Intern Med 118 1993 770 778
49. J. Drazen Relationship between 5-LO gene promoter mutations and lung function response to 5-LO inhibition Am J Respir Crit Care Med 155 1997 A257
50. J.M. Drazen H.A. Boushey S.T. Holgate The pathogenesis of severe asthma: A consensus report from the workshop on pathogenesis J Allerg Clin Invest 1987 428 437
51. J. Dutoit C. Salome A. Woolcock Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not Am Rev Respir Dis 136 1987 1174 1178
52. I. Erjefalt C. Persson Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen Acta Physiol Scand 128 1986 653 654
53. I. Erjefalt C. Persson Long duration and high potency of anti-exudative effects of formoterol in guinea-pig tracheobronchial airways Am Rev Respir Dis 144 1991 788 791
54. I. Erjefalt C. Persson Pharmacologic control of plasma exudation into tracheobronchial airways Am Rev Respir Dis 143 1991 1008 1014
55. M. Estenne J. Yernault De Troyer A. Effects of parenteral aminophylline on lung mechanics in normal humans Am Rev Respir Dis 121 1980 967 971
56. D. Evans D. Taylor O. Zetterstrom A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma N Engl J Med 337 1997 1412 1418
57. J. Fahy H. Fleming H. Wong The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects Am J Respir Crit Care Med 155 1997 1828 1834
58. A. Fels N. Pawlowski E. Cramer Human alveolar macrophages produce leukotriene-B4 Proc Natl Acad Sci USA 79 1982 7866 7870
59. G. Fink M. Mittelman B. Shohat Theophylline-induced alterations in cellular immunity in asthmatic patients Clin Allergy 17 1987 313 316
60. J. Finnerty C. Lee S. Wilson Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: A placebo-controlled parallel group study Eur Respir J 9 1996 1672 1677
61. J. FitzGerald K. Chapman Della Cioppa G. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity J Allergy Clin Immunol 103 1999 427 435
62. P. Gardiner C. Ward H. Booth Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics Am J Respir Crit Care Med 150 1994 1006 1011
63. G. Gauvreau J. Doctor R. Watson Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation Am J Respir Crit Care Med 154 1996 1267 1271
64. G. Gayan-Ramirez S. Janssens B. Himpens Mechanism of theophylline-induced inotropic effects on forshortened canine diaphragm Eur Respir J 8 1995 1915 1921
65. P. Gibson Allergen-induced asthmatic responses: Relationship between increases in airway responsiveness and increase in circulating eosinophils, basophils and their progenitors Am Rev Respir Dis 143 1991 331
66. A. Greening P. Wind M. Northfield Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid Lancet 344 1994 219 224
67. L. Greiff P. Wollmer M. Andersson Effects of formoterol on histamine-induced plasma exudation in induced sputum from normal subjects Thorax 53 1998 1010 1013
68. S. Grewe S.C. Chan J. Hanifin Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: A possible mechanism for cyclic AMP-agonist hyporesponsiveness J Allergy Clin Immunol 70 1982 452 457
69. T. Haahtela M. Jarvinen T. Kava Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma N Engl J Med 331 1994 700 705
70. E. Hamelmann A. Oshiba J. Loader Anti-interleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization Am J Respir Crit Care Med 155 1997 819 825
71. 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: Correlation with receptor autoradiography Eur J Pharmacol 206 1991 133 138
72. A. Hatzelmann H. Tenor C. Schudt Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions Br J Pharmacol 114 1995 821 831
73. L. Hendeles E. Harman D. Huang Theophylline attenuation of airway responses to allergen: Comparison with cromolyn metered-dose inhaler J Allergy Clin Immunol 95 1995 505 514
74. M. Higbee M. Kumar S. Galant Stimulation of endogenous catecholamine release by theophylline: A proposed additional mechanism of action for theophylline effects J Allergy Clin Immunol 70 1982 377 382
75. J. Hoag E.J. McFadden Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: A review Ann Allergy 66 1991 53 63
76. R. Howell Multiple mechanisms of xanthine actions on airway reactivity J Pharmacol Exp Ther 225 1990 1008 1014
77. K. Hui J. Lotvall K. Chung Attenuation of inhaled allergen-induced airway microvascular leakage and airflow obstruction in guinea pigs by a 5-lipoxygenase inhibitor (A-63162) Am Rev Respir Dis 143 1991 1015 1019
78. P. Ind Anti-leukotriene intervention: Is there adequate information for clinical use in asthma? Respir Med 90 1996 575 586
79. E. Israel J. Cohn L. Dube Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma JAMA 275 1996 931 936
80. Z. Jaffar P. Sullivan C. Page Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics Eur Respir J 9 1996 456 462
81. F. Johansson I. Rydberg G. Aberg Effects of albuterol enantiomers on in vitro bronchial reactivity Clin Rev Allergy Immunol 14 1996 57 64
82. M. Johnson β2-Agonists as anti-inflammatory therapies in the lung Agents Actions Suppl 41 1993 27 45
83. E. Juniper P. Johnston C. Borkhoff Quality of life in asthma clinical trials: Comparison of salmeterol and salbutamol Am J Respir Crit Care Med 151 1995 66 70
84. E. Juniper P. Kline M. Vanzieleghem Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics Am Rev Respir Dis 142 1990 832 836
85. G. Kane M. Pollice C. Kim A controlled trial of the effects of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings J Allergy Clin Immunol 97 1996 646 654
86. W. Kelly I. Hudson J. Raven Childhood asthma and adult lung function Am Rev Respir Dis 138 1988 26 30
87. Kerrebijn K. van Essen-Zandvliet E. H. Neijens Effects of long-term treatment with inhaled corticosteroids and β-agonists on the bronchial responsiveness in children with asthma J Allergy Clin Immunol 79 1987 653 659
88. S. Kharitonov K. Alving P. Barnes Exhaled nasal nitric oxide measurements: Recommendations Eur Respir J 10 1997 1683 1693
89. S. Kharitonov D. Yates R. Robbins Increased nitric oxide in exhaled air of asthmatic patients Lancet 343 1994 133 135
90. J. Kidney M. Dominguez P. Taylor Immunomodulation by theophylline in asthma Am J Respir Crit Care Med 151 1995 1907 1914
91. I. Kioumis D. Ukena P. Barnes Effect of nedocromil sodium on down-regulation of pulmonary β-adrenoceptors Clin Sci 76 1989 599 602
92. O. Kon B. Sihra C. Compton Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma Lancet 352 1998 1109 1113
93. M. Kraft R. Djukanovic S. Wilson Alveolar tissue inflammation in asthma Am J Respir Crit Care Med 154 1996 1505 1510
94. M. Kraft J. Torvik J. Trudeau Theophylline: Potential anti-inflammatory effects in nocturnal asthma J Allergy Clin Immunol 97 1996 1242 1246
95. M. Kraft S. Wenzel C. Bettinger The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma Chest 111 1997 1249 1254
96. C. Lai C. Chan S. Ho Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids Chest 108 1995 36 40
97. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial J Allergy Clin Immunol 90 1992 32 42
98. L. Laitinen A. Laitinen T. Haahtela Leukotriene-E4 and granulocytic infiltration into asthmatic airways Lancet 341 1993 989 990
99. S. Lal P.D. Dorrow K.K. Venho Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease Chest 104 1993 438 447
100. V. Langente M. Pruniaux J. Junien Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors Am J Respir Crit Care Med 151 1995 1720 1724
101. 2-adrenoceptor agonists on mast cells of rat, guinea pig, and human Int Arch Allergy Immunol 105 1994 177 180
102. K. Leung K. Flint J. Brostoff Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells Thorax 43 1988 756 761
103. S. Lim A. Jatakanon M. John Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma Am J Respir Crit Care Med 159 1999 22 30
104. M. Liu L. Dube J. Lancaster Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial J Allergy Clin Immunol 98 1996 859 871
105. R. Lundgren M. Soderberg P. Horstedt Morphological studies of bronchial mucosal biopsies from asthmatics before and after 10 years of treatment with inhaled steroids Eur Respir J 1 1988 883 889
106. 2-adrenergic receptor transcription in human lung Am J Physiol 12 1995 L41 L46
107. 2-adrenergic receptors in vivo J Clin Invest 96 1995 99 106
108. N. Manolitsas J. Wang J. Devalia Regular albuterol, nedrocromil sodium, and bronchial inflammation in asthma Am J Respir Crit Care Med 151 1995 1925 1930
109. J. Mascali P. Cvietusa J. Negri Anti-inflammatory effects of theophylline: Modulation of cytokine production Ann Allergy Asthma Immunol 77 1996 334 338
110. G. Massaro C. Fischman M. Chiang Regulation of secretion in Clara cells: studies using the isolated perfused lung J Clin Invest 67 1981 345 351
111. P. Mauser A. Pitman X. Fernandez Effects of an antibody to interleukin-5 in a monkey model of asthma Am J Respir Crit Care Med 152 1995 467 472
112. 2-selective sympathomimetics Pulm Pharmacol Ther 7 1994 367 376
113. R. McIvor E. Pizzichini M. Turner Potential masking effects of salmeterol on airway inflammation in asthma Am J Respir Crit Care Med 158 1998 924 930
114. Y. Mekori D. Baram A. Goldberg Nedrocromil sodium inhibits T-cell function in vitro and in vivo J Allergy Clin Immunol 91 1993 817 824
115. S. Mitra M. Ugur O. Ugur (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle Mol Pharmacol 53 1997 347 354
116. P. Montuschi M. Corradi G. Ciabattoni Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients Am J Respir Crit Care Med 160 1999 216 220
117. J. Mortenson S. Groth P. Lange Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurized inhaler and a dry powder inhaler Thorax 46 1991 817 823
118. National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the diagnosis and management of asthma 1997 National Institute of Health Bethesda, MD
119. S. Nasser G. Bell S. Foster Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma Thorax 49 1994 749 756
120. E. Nassif M. Weinberger R. Thompson The value of maintenance theophylline in steroid-dependent asthma N Engl J Med 304 1988 71 75
121. H. Nelson β-Adrenergic bronchodilators N Engl J Med 333 1995 499 506
122. H. Nelson G. Bensch W. Pleskow Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma J Allergy Clin Immunol 102 1998 943 952
123. H. Nelson D.J. Raine H. Doner Subsensitivity to the bronchodilator action of albuterol produced by chronic administration Am Rev Respir Dis 116 1977 871 878
124. J. Nelson L. Strauss M. Skowronski Effect of long-term salmeterol treatment on exercise-induced asthma N Engl J Med 339 1998 141 146
125. D. Newnham D. McDevitt B. Lipworth Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma Am J Med 98 1994 29 37
126. 2-agonists Am J Respir Crit Care Med 150 1994 381 387
127. 2-agonists in asthma N Engl J Med 327 1992 1204 1208
128. K. Ohta S. Sawamoto M. Nakajima The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis Clin Exp Allergy 26 suppl 2 1996 10 15
129. D. Oliveri A. Chetta Del Donno M. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: A placebo-controlled study Am J Respir Crit Care Med 155 1997 1864 1871
130. N. Pearce R. Beasley J. Crane End of the New Zealand asthma mortality epidemic Lancet 345 1995 41 44
131. D.S. Pearlman P. Chervinsky C. LaForge A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma N Engl J Med 327 1992 1420 1425
132. J. Peat A. Woolcock K. Cullen Rate of decline of lung function in subjects with asthma Eur J Respir Dis 70 1987 171 179
133. M. Perrin-Fayolle Salbutamol in the treatment of asthma Lancet 346 1995 1101
134. M. Peters I. Adcock C. Brown β-Adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung Eur J Pharmacol 289 1995 275 281
135. M. Peters I. Adcock C. Brown β-Agonist inhibition of steroid-receptor DNA binding activity in human lung Am Rev Respir Dis 147 1993 A772
136. T. Petty D. Rollins K. Christopher Cromolyn sodium is effective in adult chronic asthmatics Am Rev Respir Dis 139 1989 694 701
137. I. Pin P. Gibson R. Zolendowicz Use of induced sputum cell counts to investigate airway inflammation in asthma Thorax 47 1992 25 29
138. M. Pizzichini E. Pizzichini L. Clelland Sputum in severe exacerbations of asthma Am J Respir Crit Care Med 155 1997 1501 1508
139. J. Polson J. Krzanowski A. Goldman Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline Clin Exp Pharmacol Physiol 5 1978 535 539
140. K. Rabe H. Tenor G. Dent Theophylline relaxes human airways and pulmonary arteries in vitro through phosphodiesterase inhibition Am Rev Respir Dis 147 suppl 1993 A184
141. H. Reddel C. Salome J. Peat Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med 151 1995 1320 1325
142. T. Reiss L. Altman P. Chervinsky Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma J Allergy Clin Immunol 98 1996 528 534
143. L. Repsher J. Anderson R. Bush Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol Chest 85 1984 34 38
144. R. Rivington L. Boulet J. Cote Efficacy of uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids Am J Respir Crit Care Med 151 1995 325 332
145. D. Robinson B. Assoufi S. Durham Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma Clin Exp Allergy 25 1995 1118 1127
146. D. Robinson Q. Hamid S. Ying Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression Am Rev Respir Dis 148 1993 401 406
147. A. Rohr S. Siegle R. Katz A comparison of inhaled albuterol and cromolyn in the prophylaxis of exercise-induced bronchospasm Ann Allergy 59 1987 107 109
148. Saatcioglu F. Claret F.-X. M. Karin Negative transcriptional regulation by nuclear receptors Semin Cancer Biol 5 1994 347 359
149. S. Sanders Nitric oxide in asthma: Pathogenic, therapeutic, or diagnostic? Am J Respir Cell Mol Biol 21 1999 147 149
150. L. Schweibert L. Beck C. Stellato Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions Allergy Clin Immunol 97 1996 143 152
151. A. Scordamaglia G. Ciprandi S. Ruffoni Theophylline and the immune response: in vitro and in vivo effects Clin Immunol Immunopathol 48 1988 238 246
152. M.R. Sears D.R. Taylor C.G. Print Regular inhaled β-agonist treatment in bronchial asthma Lancet 336 1990 1391 1396
153. O. Selroos A. Pietinalho Lofroos A.-B. Effect of early vs late intervention with inhaled corticosteroids in asthma Chest 108 1995 1228 1234
154. 4 by human eosinophils Clin Exp Immunol 56 1984 716 722
155. U. Siebenlist G. Fanzoso K. Brown Structure, regulation, and function of NF-κB Annu Rev Cell Dev Biol 10 1994 405 455
156. Simons F. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. A comparison of beclomethasone, salmeterol, and placebo in children with asthma N Engl J Med 337 1997 1659 1665
157. 4 in humans. Effect of indomethacin Am Rev Respir Dis 141 1990 1441 1445
158. J. Sont L. Willems E. Bel Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment Am J Respir Crit Care Med 159 1999 1043 1051
159. S. Spector L. Smith M. Glass Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene-D4 receptor antagonist, in subjects with bronchial asthma Am J Respir Crit Care Med 150 1994 618 623
160. W.O. Spitzer S. Suissa P. Ernst The use of β-agonists and the risk of death and near death from asthma N Engl J Med 326 1992 501 506
161. S. Suissa P. Ernst Boivin J.-F. A cohort analysis of excess mortality in asthma and the use of inhaled β-agonists Am J Respir Crit Care Med 149 1994 604 610
162. P. Sullivan S. Bekir Z. Jaffar Anti-inflammatory effects of low-dose oral theophylline in atopic asthma Lancet 343 1994 1006 1008
163. U. Svendsen L. Frolund F. Madsen A comparison of the effects of sodium cromoglycate and beclomethasone dipropionate on pulmonary function and bronchial hyperreactivity in subjects with asthma J Allergy Clin Immunol 80 1987 68 74
164. J. Tamaoki M. Kondo N. Sakai Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid Am J Respir Crit Care Med 1997 1997 1235 1240
165. D. Taylor M. Sears G. Herbison Regular inhaled β-agonist in asthma: Effects on exacerbation and lung function Thorax 48 1993 134 138
166. I.K. Taylor K.M. O'Shaughnessy R.W. Fuller Effect of cysteinyl-leukotriene receptor antagonist ICI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects Lancet 337 1991 690 694
167. T. Thorel M. Joseph A. Tsicopoulos Inhibition by nedocromil sodium of Ig-E–mediated activation of human mononuclear phagocytes and platelets in allergy Int Arch Allergy Appl Immunol 85 1988 232 237
168. T. Torphy Phosphodiesterase isozymes Am J Respir Crit Care Med 157 1998 351 370
169. T. Torphy G. Rinard M. Rietola Functional antagonism in canine tracheal smooth muscle: Inhibition by methacholine of the mechanical and biochemical responses to isoproterenol J Pharmacol Exp Ther 227 1983 694 699
170. C.J. Trigg N.D. Manolitsas J. Wang Placebo-controlled immunopathologic study of 4 months of inhaled corticosteroids in asthma Am J Respir Crit Care Med 150 1994 17 22
171. C. Ulrik J. Frederiksen Mortality and markers of risk of asthma death among 1075 outpatients in asthma Chest 108 1995 10 15
172. C. Ulrik P. Lange Decline of lung function in adults with bronchial asthma Am J Respir Crit Care Med 150 1994 629 634
173. van Schayck C. E. Dompeling C. Herwaarden Bronchodilator treatment in moderate asthma or chronic bronchitis: Continuous or on demand? A randomized controlled study BMJ 303 1991 1426 1431
174. R. Vassallo J. Lipsky Theophylline: Recent advances in the understanding of its mode of action and uses in clinical practice Mayo Clin Proc 73 1998 346 354
175. A. Vathenen A. Knox B. Higgins Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline Lancet i 1988 554 558
176. P. Venge Soluble markers of allergic inflammation Allergy 49 1994 1 8
177. A. Verberne C. Frost R. Roorda One-year treatment with salmeterol compared with beclomethasone in children with asthma Am J Respir Crit Care Med 156 1997 688 695
178. D. Vervloet T. Ekstrom R. Pela A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease Respir Med 92 1998 836 842
179. G. Volcheck G. Gleich H. Kita Pro- and anti-inflammatory effects of β-adrenergic agonists on eosinophil response to IL-5 J Allergy Clin Immunol 101 1998 S35
180. 2-agonist treatment Am Rev Respir Dis 148 1993 707 712
181. T. Walle E. Eaton U. Walle Stereoselective metabolism of RS-albuterol in humans Clin Rev Allergy Immunol 14 1996 101 113
182. N. Wallen H. Kita D. Weiller Glucocorticoids inhibit cytokine-mediated eosinophil survival J Immunol 147 1991 3490 3495
183. A. Wallin T. Sandstrom M. Soderberg The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma Am J Respir Crit Care Med 158 1998 79 86
184. Wang Z.-L. A. Bramley A. McNamara Chronic fenoterol exposure increases in vivo and in vitro airway responses in guinea pigs Am J Respir Crit Care Med 149 1994 960 965
185. A. Ward M. McKenniff J. Evans Theophylline—an immunomodulatory role in asthma? Am Rev Respir Dis 147 1993 518 523
186. A.J. Wardlaw Eosinophils and mast cells in bronchoalveolar lavage and mild asthma: relationship to bronchial hyperreactivity Am Rev Respir Dis 137 1988 62 69
187. M. Weinberger L. Hendeles Theophylline in asthma N Engl J Med 334 1996 1380 1388
188. S. Wenzel G. Larsen K. Johnston Elevated levels of leukotriene-C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge Am Rev Respir Dis 142 1990 112 119
189. S. Wenzel L. Schwartz E. Langmack Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics Am J Respir Crit Care Med 160 1999 1001 1008
190. S. Wenzel J. Westcott G. Larsen Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: Relationship to the development of late asthmatic responses J Allergy Clin Immunol 87 1991 540 548
191. L. Wiegand C. Mende G. Zaidel Sleep and efficacy outcomes in patients with nocturnal asthma Chest 115 1999 1525 1532
192. B. Wong E. Dolovich E. Ramsdale Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses Am Rev Respir Dis 146 1992 1156 1160
193. C. Wong I. Wahedna I. Pavord Effect of regular terbutaline and budesonide on bronchial reactivitity to allergen challenge Am J Respir Crit Care Med 150 1994 1268 1273
194. A. Woolcock B. Lundback N. Ringdal Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids Am J Respir Crit Care Med 153 1996 1481 1488
195. H. Yamaguchi J. McCullough S-albuterol exacerbates calcium responses to carbachol in airway smooth muscle cells Clin Rev Allergy Immunol 14 1996 47 55
196. T. Yokomizo T. Izumi K. Chang A G-protein–coupled receptor for leukotriene-B4 that mediates chemotaxis Nature 387 1997 620 624